| M&G (LUX) JAPAN FUND GBP CI ACC | RVI JAPÓN | 48,16% | 72,20% | 102,41% | · |
| ABANTE GLOBAL FUNDS - ABANTE LIFE SCIENCES FUND A USD CAP | RVI BIOTECNOLOGÍA | 48,15% | 48,05% | 4,31% | · |
| AB FCP I-EMERGING MARKETS GROWTH PORTFOLIO I USD | RVI EMERGENTES CRECIMIENTO | 48,15% | 70,73% | 38,86% | 125,94% |
| BGF WORLD TECHNOLOGY D2 GBP | RVI TECNOLOGÍA | 48,15% | 123,51% | 86,00% | 773,17% |
| JPMORGAN ETFS(IRL)ICAV-GLOBAL EM RESEARCH ENHANCED INDEX EQUITY ACTIVE UCITS ETF USD (ACC) | RVI EMERGENTES | 48,15% | 76,95% | 45,96% | · |
| WELLINGTON ASIAN OPPORTUNITIES FUND S EUR ACC | RVI ASIA EX-JAPÓN VALOR | 48,15% | 71,23% | 36,03% | · |
| ABANTE GLOBAL FUNDS - ABANTE LIFE SCIENCES FUND C USD CAP | RVI BIOTECNOLOGÍA | 48,14% | 48,06% | 4,35% | · |
| FIDELITY FUNDS-ASIA EQUITY ESG Y-ACC-EUR | RVI ASIA EX-JAPÓN | 48,13% | 56,91% | 30,11% | 160,77% |
| MSIF ASIA EQUITY Z (USD) | RVI ASIA EX-JAPÓN | 48,12% | 83,29% | 62,17% | · |
| ALLIANZ EMERGING MARKETS EQUITY SRI A EUR | RVI EMERGENTES | 48,11% | 77,21% | · | · |
